Lucija Tomljenovic, PhD, earlier this year delivered a lecture at the 4th International Symposium on Vaccines, in Leipzig, Germany. The title of her session was: Is There Objective Evidence That the Current HPV Vaccination Programs are not Justified? Dr. Tomljenovic asks: what is the evidence, if any, that the HPV vaccine prevents cervical cancer and, therefore, can offer long-term benefits? Those perceived benefits have to justify the severe adverse reactions to the vaccines, which include postural orthostatic tachycardia syndrome (POTS), Primary Ovarian Failure, among many other autoimmune disorders. What the clinical trials for HPV have shown is that they can prevent some portion of lesions caused by HPV-16 and -18 viruses. And so, obviously, it was deduced from that it’s likely that the vaccine would prevent cervical cancer. The issue is, can someone make such a leap making such a conclusion?
In chaos theory, there is a familiar metaphor known as the “butterfly effect” that suggests small changes in initial conditions (the flapping of a butterfly’s wings) can result in large differences in a later state (the pattern of a hurricane). In the area of vaccine safety, we’ve seen this play out time and again; most recently, when the misrepresentation of study data on minute components of HPV vaccines, presented before a small gathering in Tokyo in 2014, resulted in a worldwide safety proclamation upon which physicians are now basing their vaccination recommendations – and young girls are suffering. In an open letter to the head of the World Health Organization, Dr. Sing Hang Lee, MD, the director of the Milford Molecular Diagnostics Laboratory in Milford, Connecticut, claims members of the WHO’s Global Advisory Committee on Vaccine Safety (GACVS) deliberately manipulated scientific data relating to the safety of HPV vaccines Gardasil® and Cervarix®. The letter states that the emails, obtained via a Freedom of Information request, clearly demonstrate members of the GAVCS, the CDC and the Japanese Ministry of Health, Labor and Welfare knew before the February 26, 2014 Tokyo public hearing that one of their own experts showed scientific evidence that HPV vaccination does increase cytokines, including tumor necrosis factor (TNF), particularly at the injection site compared to other vaccines.
On September 28, 2016 the Daily Mail Online reported that scientists in Reading had discovered a possible link between antiperspirants and breast cancer. To my knowledge, this is the first time that a report has mentioned that the use of these products containing aluminum in prepubescent and teenage children may not only be a risk for breast cancer, but also disrupts their hormonal development and is linked to other health problems.
Why did citizens of China have to petition their government for access to clinical trial data currently available via multiple national and international government sponsored internet sites? Why is information regarding HPV vaccines which is open for public view throughout most of the world deemed a ‘trade secret’ in China? These questions are particularly relevant when you consider the heated controversy surrounding HPV vaccination programs in so many countries around the world. Is it possible that Director Bi Jing-quan, leader of China’s State Bureau of Food & Drug Administration knows information contained in clinical trial data would reveal substantial safety concerns surrounding HPV vaccines? Does Director Bi Jing-quan think the citizens of China would be eager to use HPV vaccines if they knew the true rate of adverse events is not known because no inert placebos were used during clinical trials? Is that one of the reasons HPV vaccine clinical trial data is a ‘trade secret’ in China?
China’s population consists of approximately 143 million females age 9-25. If human papillomavirus (HPV) vaccine manufacturers can convince the Chinese government to vaccinate every woman in this age group with 3 doses of HPV vaccine via a Publicly Funded Program as proposed by two of their paid consultants, the revenue generated could amount to over $64 billion USD (using price of HPV vaccines sold in the USA at $150/dose). This staggering amount of money would provide an enormous impact to their bottom line. But the question is at what cost?
The film VAXXED continues to be shown in new cities across the U.S., with the film crew also traveling to these cities to sponsor Q&A sessions after the filming. Producer Del Bigtree states that the story of the CDC whistleblower and cover-up told in the film is "Bigger than Watergate." The film crew also often films parents of vaccine damaged or vaccine killed children who turn out to view the film and tell their own stories. The story in the video here is about Colton Berrett, who received the Gardasil HPV vaccine at 13 years old, and soon afterwards became paralyzed from the neck down. After many months of recovery, he still needs a breathing apparatus and still suffers some paralysis. His mother states in the interview that they are still seeing the same pediatrician, who reported the vaccine to VAERS, and no longer gives the vaccine to boys, and cautions girls as well. Colton has regained his speech, and also speaks during the interview.
Nordic Cochrane Research Center Files Complaint About Scientific Misconduct, Secrecy in HPV Vaccine Probe
Nordic Cochrane Center, a Danish research and information center is challenging the European Medicines Agency’s (EMA) 2015 report on human papillomavirus (HPV) vaccines and the EMA’s position that HPV vaccine benefits outweigh the risks. After numerous reports of HPV vaccine-related brain and immune system injuries and deaths, the Danish Health and Medicines Authority asked the EMA to conduct the probe into HPV vaccine safety, but prominent physicians in the country are not convinced about the EMA’s conclusions downplaying the vaccine’s risks. On May 26, 2016, the Nordic Cochrane Center filed an official complaint charging the EMA with “maladministration” and citing flaws throughout the agency’s report. The EMA replied that it has received the complain and will respond after carefully considering all the issues raised by the research group. The Nordic Cochrane Center is an independent research and information center that is part of Cochrane, an international network of individuals and institutions committed to preparing, maintaining, and disseminating systematic reviews of the effects of health care.
Health authorities and the media relentlessly repeat the mantra that vaccines are unequivocally safe, and many uninformed consumers cling to this mantra like a lifeboat. More often than not, however, consumers know little or nothing about the vaccine safety testing process and assume that vaccine manufacturers and regulatory institutions have exercised due diligence in ensuring that vaccines are as safe as possible. In an ordinary clinical trial, investigators compare a group that receives a drug with another group that receives a harmless placebo. Not so with vaccine clinical trials, many of which use placebos that contain an aluminum adjuvant. What are the implications of using aluminum-based placebos that are not innocuous or inert but instead are “intrinsically capable of stimulating pathological immune and neuro-inflammatory responses”? This is one of the critically important questions that Dr. Yehuda Shoenfeld and colleagues at Tel Aviv University and University of British Columbia researchers Lucija Tomljenovic and Christopher Shaw address in a July 2016 study in Immunologic Research about aluminum adjuvants and the quadrivalent Gardasil vaccine that ostensibly protects against four types of human papillomavirus (HPV). Dr. Shoenfeld and colleagues begin and end with the assertion that aluminum-containing placebos represent both a scientifically and ethically inappropriate choice for vaccine clinical trials, given aluminum’s well-documented neuro- and immunotoxic properties.
The American Cancer Society issued a press release recently stating that they were agreeing with the U.S. Center for Disease Control's (CDC) recommendation to now start vaccinating boys as well as girls with the Gardasil vaccine, and that Gardasil vaccines can begin as young as age 9. Noticeably absent from the press release was any warnings on Gardasil risks and side effects, or any mention of how other countries around the world are now investigating the vaccine due to the amount of injuries being reported. Japan and other nations have actually withdrawn their recommendation of the HPV vaccine. Because the manufacturers of vaccines are not immune from liabilities due the harm their vaccines cause in these countries, in contrast to the United States where one cannot sue a vaccine manufacturer, many are taking legal actions against HPV manufacturers. You will read none of this in U.S. mainstream media.
It is rare when a mainstream media source covers the story of a vaccine injury or death. When it does happen, it is usually a local news station reporting about someone in their community. WJBF out of South Carolina recently reported about a 12 year old girl who is suffering from POTS (Postural Tachycardia Syndrome) after receiving the Gardasil vaccine. POTS is a condition in which an excessively reduced volume of blood returns to the heart after an individual stands up from a lying down position. The primary symptom is lightheadedness or fainting. This once active young girl can now barely walk. Her mother says the vaccine robbed her daughter of her life.